Neumedicines Inc. Receives an Award of $8.3 Million From Biomedical Advanced Research and Development Authority (BARDA) for Continued Development of HemaMax as a Countermeasure to Acute Radiation Exposure
6/10/2013 10:03:12 AM
More...
|
Chimerix, Inc. and Biomedical Advanced Research and Development Authority (BARDA) Continue Collaboration on Development of CMX001 as a Medical Countermeasure Against Smallpox
6/3/2013 10:27:30 AM
More...
|
SIGA Technologies, Inc. (SIGA) Completes Second Delivery of Arestvyr™ Under Biomedical Advanced Research and Development Authority (BARDA) Contract
5/29/2013 9:40:47 AM
More...
|
The $58 Million Antibiotic: Cempra Pharmaceuticals, Inc. Wins Five-Year Contract From Biomedical Advanced Research and Development Authority (BARDA)
5/28/2013 8:35:27 AM
More...
|
Neumedicines Inc. Receives Biomedical Advanced Research and Development Authority (BARDA) Notification of Intent to Exercise Contract Option to Continue Development of HemaMax as Radiation Medical Countermeasure
5/14/2013 10:06:31 AM
More...
|
Achaogen Lands $60 Million Biomedical Advanced Research and Development Authority (BARDA) Contract
4/24/2013 11:28:16 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Continues Support of Flublok® and Panblok® Influenza Vaccines
2/19/2013 9:31:23 AM
More...
|
Cleveland Biolabs Inc. (CBLI) to Present at Biomedical Advanced Research and Development Authority (BARDA) and National Institute of Allergy And Infectious Diseases (NIAID) Sponsored Symposium on Development of Radiation Medical Countermeasures
1/24/2013 9:26:54 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Continues Novavax, Inc. (NVAX)' Influenza Vaccine Programs Following In-Process Review
1/24/2013 9:21:30 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Exercises Contract Option as Emergent BioSolutions (EBS) Achieves Significant Progress in rPA Anthrax
10/5/2012 9:43:44 AM
More...
|
|